181 related articles for article (PubMed ID: 35768547)
21. A broad requirement for TLS polymerases η and κ, and interacting sumoylation and nuclear pore proteins, in lesion bypass during C. elegans embryogenesis.
Roerink SF; Koole W; Stapel LC; Romeijn RJ; Tijsterman M
PLoS Genet; 2012 Jun; 8(6):e1002800. PubMed ID: 22761594
[TBL] [Abstract][Full Text] [Related]
22. Structural insights into the assembly of human translesion polymerase complexes.
Xie W; Yang X; Xu M; Jiang T
Protein Cell; 2012 Nov; 3(11):864-74. PubMed ID: 23143872
[TBL] [Abstract][Full Text] [Related]
23. REV7 is required for anaphase-promoting complex-dependent ubiquitination and degradation of translesion DNA polymerase REV1.
Chun AC; Kok KH; Jin DY
Cell Cycle; 2013 Jan; 12(2):365-78. PubMed ID: 23287467
[TBL] [Abstract][Full Text] [Related]
24. HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers.
El-Botty R; Vacher S; Mainguené J; Briaux A; Ibadioune S; Dahmani A; Montaudon E; Nemati F; Huguet L; Sourd L; Morriset L; Château-Joubert S; Dubois T; Maire V; Lidereau R; Rapinat A; Gentien D; Coussy F; Bièche I; Marangoni E
Mol Oncol; 2023 Oct; 17(10):2017-2028. PubMed ID: 36852691
[TBL] [Abstract][Full Text] [Related]
25. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
Pustovalova Y; Maciejewski MW; Korzhnev DM
J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
[TBL] [Abstract][Full Text] [Related]
26. Y-family DNA polymerase-independent gap-filling translesion synthesis across aristolochic acid-derived adenine adducts in mouse cells.
Hashimoto K; Bonala R; Johnson F; Grollman AP; Moriya M
DNA Repair (Amst); 2016 Oct; 46():55-60. PubMed ID: 27497692
[TBL] [Abstract][Full Text] [Related]
27. HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress.
Nichols BA; Oswald NW; McMillan EA; McGlynn K; Yan J; Kim MS; Saha J; Mallipeddi PL; LaDuke SA; Villalobos PA; Rodriguez-Canales J; Wistuba II; Posner BA; Davis AJ; Minna JD; MacMillan JB; Whitehurst AW
Cancer Res; 2018 Nov; 78(21):6196-6208. PubMed ID: 30185546
[TBL] [Abstract][Full Text] [Related]
28. TopBP1-mediated DNA processing during mitosis.
Gallina I; Christiansen SK; Pedersen RT; Lisby M; Oestergaard VH
Cell Cycle; 2016; 15(2):176-83. PubMed ID: 26701150
[TBL] [Abstract][Full Text] [Related]
29. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
Dyson OF; Pagano JS; Whitehurst CB
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1.
Hara K; Hashimoto H; Murakumo Y; Kobayashi S; Kogame T; Unzai S; Akashi S; Takeda S; Shimizu T; Sato M
J Biol Chem; 2010 Apr; 285(16):12299-307. PubMed ID: 20164194
[TBL] [Abstract][Full Text] [Related]
31. Proteasomal regulation of the mutagenic translesion DNA polymerase, Saccharomyces cerevisiae Rev1.
Wiltrout ME; Walker GC
DNA Repair (Amst); 2011 Feb; 10(2):169-75. PubMed ID: 21227758
[TBL] [Abstract][Full Text] [Related]
32. DNA polymerase ζ in DNA replication and repair.
Martin SK; Wood RD
Nucleic Acids Res; 2019 Sep; 47(16):8348-8361. PubMed ID: 31410467
[TBL] [Abstract][Full Text] [Related]
33. Filling gaps in translesion DNA synthesis in human cells.
Quinet A; Lerner LK; Martins DJ; Menck CFM
Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt B):127-142. PubMed ID: 30442338
[TBL] [Abstract][Full Text] [Related]
34. Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesions.
Plo I; Liao ZY; Barceló JM; Kohlhagen G; Caldecott KW; Weinfeld M; Pommier Y
DNA Repair (Amst); 2003 Oct; 2(10):1087-100. PubMed ID: 13679147
[TBL] [Abstract][Full Text] [Related]
35. Rev1 promotes replication through UV lesions in conjunction with DNA polymerases η, ι, and κ but not DNA polymerase ζ.
Yoon JH; Park J; Conde J; Wakamiya M; Prakash L; Prakash S
Genes Dev; 2015 Dec; 29(24):2588-602. PubMed ID: 26680302
[TBL] [Abstract][Full Text] [Related]
36. The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition.
Rizzo AA; Korzhnev DM
Enzymes; 2019; 45():139-181. PubMed ID: 31627876
[TBL] [Abstract][Full Text] [Related]
37. Implications of Translesion DNA Synthesis Polymerases on Genomic Stability and Human Health.
Venkadakrishnan J; Lahane G; Dhar A; Xiao W; Bhat KM; Pandita TK; Bhat A
Mol Cell Biol; 2023; 43(8):401-425. PubMed ID: 37439479
[TBL] [Abstract][Full Text] [Related]
38. Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer.
Lee KJ; Piett CG; Andrews JF; Mann E; Nagel ZD; Gassman NR
PLoS One; 2019; 14(10):e0223725. PubMed ID: 31596905
[TBL] [Abstract][Full Text] [Related]
39. Interaction with DNA polymerase eta is required for nuclear accumulation of REV1 and suppression of spontaneous mutations in human cells.
Akagi J; Masutani C; Kataoka Y; Kan T; Ohashi E; Mori T; Ohmori H; Hanaoka F
DNA Repair (Amst); 2009 May; 8(5):585-99. PubMed ID: 19157994
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ.
Wojtaszek J; Lee CJ; D'Souza S; Minesinger B; Kim H; D'Andrea AD; Walker GC; Zhou P
J Biol Chem; 2012 Sep; 287(40):33836-46. PubMed ID: 22859295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
